Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects

Clinical trial NCT03224338 · COMPLETED

Trial details

NCT number: NCT03224338
Sponsor: Blueclinical, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV II Infection

Start date: 2017-04-05
Primary completion: 2019-07-02
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.